Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 435

1.

Perceptions matter: Narratives of contraceptive implant robbery in Cape Town, South Africa.

Krogstad EA, Atujuna M, Montgomery ET, Minnis AM, Morroni C, Bekker LG.

Cult Health Sex. 2020 Mar 27:1-14. doi: 10.1080/13691058.2020.1714739. [Epub ahead of print]

PMID:
32216584
2.

The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.

Velloza J, Khoza N, Scorgie F, Chitukuta M, Mutero P, Mutiti K, Mangxilana N, Nobula L, Bulterys MA, Atujuna M, Hosek S, Heffron R, Bekker LG, Mgodi N, Chirenje M, Celum C, Delany-Moretlwe S; HPTN 082 study group.

J Int AIDS Soc. 2020 Mar;23(3):e25463. doi: 10.1002/jia2.25463.

3.

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.

Laher F, Moodie Z, Cohen KW, Grunenberg N, Bekker LG, Allen M, Frahm N, Yates NL, Morris L, Malahleha M, Mngadi K, Daniels B, Innes C, Saunders K, Grant S, Yu C, Gilbert PB, Phogat S, DiazGranados CA, Koutsoukos M, Van Der Meeren O, Bentley C, Mkhize NN, Pensiero MN, Mehra VL, Kublin JG, Corey L, Montefiori DC, Gray GE, McElrath MJ, Tomaras GD.

PLoS Med. 2020 Feb 24;17(2):e1003038. doi: 10.1371/journal.pmed.1003038. eCollection 2020 Feb.

4.

World AIDS Day reminds us to refocus on communities.

Yola N, Mpongo CN, Latief I, Bekker LG.

Indian J Med Res. 2019 Dec;150(6):518-520. doi: 10.4103/ijmr.IJMR_2662_19. No abstract available.

5.

TB transmission is associated with prolonged stay in a low socio-economic, high burdened TB and HIV community in Cape Town, South Africa.

Tadokera R, Bekker LG, Kreiswirth BN, Mathema B, Middelkoop K.

BMC Infect Dis. 2020 Feb 10;20(1):120. doi: 10.1186/s12879-020-4828-z.

6.

HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens.

Shen X, Laher F, Moodie Z, McMillan AS, Spreng RL, Gilbert PB, Huang Y, Yates NL, Grunenberg N, Juliana McElrath M, Allen M, Pensiero M, Mehra VL, Der Meeren OV, Barnett SW, Phogat S, Gray GE, Bekker LG, Corey L, Tomaras GD.

Sci Rep. 2020 Feb 7;10(1):2093. doi: 10.1038/s41598-020-57491-z.

7.

The impact of self-selection based on HIV risk on the cost-effectiveness of pre-exposure prophylaxis in South Africa.

Jamieson L, Gomez GB, Rebe K, Brown B, Subedar H, Jenkins S, Shoko N, Bekker LG, Johnson LF, Meyer-Rath G.

AIDS. 2020 Jan 30. doi: 10.1097/QAD.0000000000002486. [Epub ahead of print]

PMID:
32004205
8.

Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection.

Ditse Z, Mkhize NN, Yin M, Keefer M, Montefiori DC, Tomaras GD, Churchyard G, Mayer KH, Karuna S, Morgan C, Bekker LG, Mlisana K, Gray G, Moodie Z, Gilbert P, Moore PL, Williamson C, Morris L.

mSphere. 2020 Jan 29;5(1). pii: e00738-19. doi: 10.1128/mSphere.00738-19.

9.

The relationship between intimate partner violence and probable depression among adolescent girls and young women in Lilongwe, Malawi.

Brar SK, Beattie TSH, Abas M, Vansia D, Phanga T, Maseko B, Bekker LG, Pettifor AE, Rosenberg NE.

Glob Public Health. 2020 Jan 29:1-12. doi: 10.1080/17441692.2020.1718732. [Epub ahead of print]

PMID:
31994453
10.

The Effect of Depression on Adherence to HIV Pre-exposure Prophylaxis Among High-Risk South African Women in HPTN 067/ADAPT.

Velloza J, Heffron R, Amico KR, Rowhani-Rahbar A, Hughes JP, Li M, Dye BJ, Celum C, Bekker LG, Grant RM; HPTN 067/ADAPT Study Team.

AIDS Behav. 2020 Jan 18. doi: 10.1007/s10461-020-02783-8. [Epub ahead of print]

PMID:
31955360
11.

Perceptions of and interest in HIV pre-exposure prophylaxis use among adolescent girls and young women in Lilongwe, Malawi.

Maseko B, Hill LM, Phanga T, Bhushan N, Vansia D, Kamtsendero L, Pettifor AE, Bekker LG, Hosseinipour MC, Rosenberg NE.

PLoS One. 2020 Jan 13;15(1):e0226062. doi: 10.1371/journal.pone.0226062. eCollection 2020.

12.

The power of peers and community in the continuum of HIV care.

Grimsrud AT, Pike C, Bekker LG.

Lancet Glob Health. 2020 Feb;8(2):e167-e168. doi: 10.1016/S2214-109X(19)30544-3. Epub 2020 Jan 7. No abstract available.

13.

Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?

Joseph Davey DL, Pintye J, Baeten JM, Aldrovandi G, Baggaley R, Bekker LG, Celum C, Chi BH, Coates TJ, Haberer JE, Heffron R, Kinuthia J, Matthews LT, McIntyre J, Moodley D, Mofenson LM, Mugo N, Myer L, Mujugira A, Shoptaw S, Stranix-Chibanda L, John-Stewart G; PrEP in Pregnancy Working Group.

J Int AIDS Soc. 2020 Jan;23(1):e25426. doi: 10.1002/jia2.25426. Review.

14.

PrEP: An Opportunity to Address Unmet Adolescent Health Needs.

Pike C, Bekker LG.

Pediatrics. 2020 Jan;145(1). pii: e20193172. doi: 10.1542/peds.2019-3172. No abstract available.

PMID:
31857379
15.

Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells.

Fisher L, Zinter M, Stanfield-Oakley S, Carpp LN, Edwards RW, Denny T, Moodie Z, Laher F, Bekker LG, McElrath MJ, Gilbert PB, Corey L, Tomaras G, Pollara J, Ferrari G.

Front Immunol. 2019 Nov 27;10:2741. doi: 10.3389/fimmu.2019.02741. eCollection 2019.

16.

The complex challenges of HIV vaccine development require renewed and expanded global commitment.

Bekker LG, Tatoud R, Dabis F, Feinberg M, Kaleebu P, Marovich M, Ndung'u T, Russell N, Johnson J, Luba M, Fauci AS, Morris L, Pantaleo G, Buchbinder S, Gray G, Vekemans J, Kim JH, Levy Y, Corey L, Shattock R, Makanga M, Williamson C, Dieffenbach C, Goodenow MM, Shao Y, Staprans S, Warren M, Johnston MI.

Lancet. 2020 Feb 1;395(10221):384-388. doi: 10.1016/S0140-6736(19)32682-0. Epub 2019 Dec 2. Review. No abstract available.

PMID:
31806257
17.

Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities.

Reddy K, Kelly C, Brown ER, Jeenarain N, Naidoo L, Siva S, Bekker LG, Nair G, Makanani B, Chinula L, Mgodi N, Chirenje Z, Kiweewa FM, Marrazzo J, Bunge K, Soto-Torres L, Piper J, Baeten JM, Palanee-Phillips T; MTN-020/ASPIRE and MTN-003/VOICE Study Teams.

AIDS. 2020 Mar 15;34(4):559-567. doi: 10.1097/QAD.0000000000002451.

PMID:
31764068
18.

The Political, Research, Programmatic, and Social Responses to Adolescent Sexual and Reproductive Health and Rights in the 25 Years Since the International Conference on Population and Development.

Chandra-Mouli V, Ferguson BJ, Plesons M, Paul M, Chalasani S, Amin A, Pallitto C, Sommers M, Avila R, Eceéce Biaukula KV, Husain S, Janušonytė E, Mukherji A, Nergiz AI, Phaladi G, Porter C, Sauvarin J, Camacho-Huber AV, Mehra S, Caffe S, Michielsen K, Ross DA, Zhukov I, Bekker LG, Celum CL, Dayton R, Erulkar A, Travers E, Svanemyr J, Maksud N, Digolo-Nyagah L, Diop NJ, Lhaki P, Adhikari K, Mahon T, Manzenski Hansen M, Greeley M, Herat J, Engel DMC.

J Adolesc Health. 2019 Dec;65(6S):S16-S40. doi: 10.1016/j.jadohealth.2019.09.011. Review.

PMID:
31761001
19.

Impact of hormonal contraceptives on cervical Th17 phenotype and function in adolescents: Results from a randomized cross-over study comparing long-acting injectable norethisterone oenanthate (NET-EN), combined oral contraceptive pills, and combined contraceptive vaginal rings.

Konstantinus IN, Balle C, Jaumdally SZ, Galmieldien H, Pidwell T, Masson L, Tanko RF, Happel AU, Sinkala M, Myer L, Bosinger SE, Gill K, Bekker LG, Jaspan HB, Passmore JS.

Clin Infect Dis. 2019 Nov 2. pii: ciz1063. doi: 10.1093/cid/ciz1063. [Epub ahead of print]

PMID:
31675420
20.

Acceptability of a long-acting injectable HIV prevention product among US and African women: findings from a phase 2 clinical Trial (HPTN 076).

Tolley EE, Li S, Zangeneh SZ, Atujuna M, Musara P, Justman J, Pathak S, Bekker LG, Swaminathan S, Stanton J, Farrior J, Sista N.

J Int AIDS Soc. 2019 Oct;22(10):e25408. doi: 10.1002/jia2.25408.

21.

TB-IRIS pathogenesis and new strategies for intervention: Insights from related inflammatory disorders.

Cevaal PM, Bekker LG, Hermans S.

Tuberculosis (Edinb). 2019 Sep;118:101863. doi: 10.1016/j.tube.2019.101863. Epub 2019 Sep 13. Review.

22.

Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa.

Gray GE, Huang Y, Grunenberg N, Laher F, Roux S, Andersen-Nissen E, De Rosa SC, Flach B, Randhawa AK, Jensen R, Swann EM, Bekker LG, Innes C, Lazarus E, Morris L, Mkhize NN, Ferrari G, Montefiori DC, Shen X, Sawant S, Yates N, Hural J, Isaacs A, Phogat S, DiazGranados CA, Lee C, Sinangil F, Michael NL, Robb ML, Kublin JG, Gilbert PB, McElrath MJ, Tomaras GD, Corey L.

Sci Transl Med. 2019 Sep 18;11(510). pii: eaax1880. doi: 10.1126/scitranslmed.aax1880.

PMID:
31534016
23.

Assessing the Impact of a Small-Group Behavioral Intervention on Sexual Behaviors Among Adolescent Girls and Young Women in Lilongwe Malawi: A Quasi-Experimental Cohort Study.

Rosenberg NE, Gichane MW, Vansia D, Phanga T, Bhushan NL, Bekker LG, Pettifor AE.

AIDS Behav. 2019 Sep 11. doi: 10.1007/s10461-019-02669-4. [Epub ahead of print]

PMID:
31512067
24.

Factors associated with knowledge of pre-exposure prophylaxis in pregnant women in Cape Town, South Africa.

DiTullio DJ, Farley E, Gomba Y, Coates TJ, Bekker LG, Myer L, Joseph Davey DL.

Int J STD AIDS. 2019 Oct;30(11):1063-1070. doi: 10.1177/0956462419863216. Epub 2019 Aug 28. No abstract available.

25.

Mobile sexual health services for adolescents: investigating the acceptability of youth-directed mobile clinic services in Cape Town, South Africa.

Smith P, Tolla T, Marcus R, Bekker LG.

BMC Health Serv Res. 2019 Aug 19;19(1):584. doi: 10.1186/s12913-019-4423-4.

26.

Community perspectives of South African adolescents' experiences seeking treatment at local HIV clinics and how such clinics may influence engagement in the HIV treatment cascade: a qualitative study.

Ritchwood TD, Ba A, Ingram L, Atujuna M, Marcus R, Ntlapo N, Oduro A, Bekker LG.

AIDS Care. 2020 Jan;32(1):83-88. doi: 10.1080/09540121.2019.1653442. Epub 2019 Aug 11.

PMID:
31402674
27.

HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery.

Celum CL, Delany-Moretlwe S, Baeten JM, van der Straten A, Hosek S, Bukusi EA, McConnell M, Barnabas RV, Bekker LG.

J Int AIDS Soc. 2019 Jul;22 Suppl 4:e25298. doi: 10.1002/jia2.25298.

28.

Brief Report: Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017).

Liu AY, Norwood A, Gundacker H, Carballo-Diéguez A, Johnson S, Patterson K, Bekker LG, Chariyalertsak S, Chitwarakorn A, Gonzales P, Holtz TH, Mayer KH, Zorrilla C, Buchbinder S, Piper JM, Lama JR, Cranston RD.

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):516-520. doi: 10.1097/QAI.0000000000002066.

PMID:
31299013
29.

Prevalence and correlates of sexually transmitted infections in pregnancy in HIV-infected and- uninfected women in Cape Town, South Africa.

Joseph Davey DL, Nyemba DC, Gomba Y, Bekker LG, Taleghani S, DiTullio DJ, Shabsovich D, Gorbach PM, Coates TJ, Klausner JD, Myer L.

PLoS One. 2019 Jul 1;14(7):e0218349. doi: 10.1371/journal.pone.0218349. eCollection 2019.

30.

Low Disclosure of PrEP Nonadherence and HIV-Risk Behaviors Associated With Poor HIV PrEP Adherence in the HPTN 067/ADAPT Study.

Ojeda VD, Amico KR, Hughes JP, Wilson E, Li M, Holtz TH, Chitwarakorn A, Grant RM, Dye BJ, Bekker LG, Mannheimer S, Marzinke M, Hendrix CW.

J Acquir Immune Defic Syndr. 2019 Sep 1;82(1):34-40. doi: 10.1097/QAI.0000000000002103.

PMID:
31169769
31.

Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project.

Spinelli MA, Glidden DV, Anderson PL, Gandhi M, McMahan VM, Defechereux P, Schechter M, Veloso VG, Chariyalertsak S, Guanira JV, Bekker LG, Buchbinder SP, Grant RM.

AIDS Res Hum Retroviruses. 2019 Sep;35(9):788-793. doi: 10.1089/AID.2018.0297. Epub 2019 Jun 19.

PMID:
31119944
32.

HIV control in young key populations in Africa.

Bekker LG.

Lancet Child Adolesc Health. 2019 Jul;3(7):442-444. doi: 10.1016/S2352-4642(19)30112-9. Epub 2019 May 16. No abstract available.

PMID:
31105054
33.

The HIV response and global health - Authors' reply.

Bekker LG, Beyrer C, Isbell M.

Lancet. 2019 Apr 27;393(10182):1697. doi: 10.1016/S0140-6736(19)30347-2. No abstract available.

PMID:
31034376
34.

Governance for health: the HIV response and general global health.

Bekker LG, Ratevosian J, Spencer J, Piot P, Beyrer C.

Bull World Health Organ. 2019 Mar 1;97(3):170-170A. doi: 10.2471/BLT.19.230417. No abstract available.

35.

Cardiovascular risk factors among ART-experienced people with HIV in South Africa.

Hyle EP, Bekker LG, Martey EB, Huang M, Xu A, Parker RA, Walensky RP, Middelkoop K.

J Int AIDS Soc. 2019 Apr;22(4):e25274. doi: 10.1002/jia2.25274.

36.

Modelling the potential impact of providing preexposure prophylaxis in pregnant and breastfeeding women in South Africa.

Joseph Davey DL, Bekker LG, Gomba Y, Coates T, Myer L, Johnson LF.

AIDS. 2019 Jul 1;33(8):1391-1395. doi: 10.1097/QAD.0000000000002221.

PMID:
30950882
37.

Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.

Dabee S, Barnabas SL, Lennard KS, Jaumdally SZ, Gamieldien H, Balle C, Happel AU, Murugan BD, Williamson AL, Mkhize N, Dietrich J, Lewis DA, Chiodi F, Hope TJ, Shattock R, Gray G, Bekker LG, Jaspan HB, Passmore JS.

PLoS One. 2019 Apr 4;14(4):e0213975. doi: 10.1371/journal.pone.0213975. eCollection 2019.

38.

Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults With Incident HIV-1 Infection.

Price MA, Rida W, Kilembe W, Karita E, Inambao M, Ruzagira E, Kamali A, Sanders EJ, Anzala O, Hunter E, Allen S, Edward VA, Wall KM, Tang J, Fast PE, Kaleebu P, Lakhi S, Mutua G, Bekker LG, Abu-Baker G, Tichacek A, Chetty P, Latka MH, Maenetje P, Makkan H, Kibengo F, Priddy F, Gilmour J.

J Infect Dis. 2019 Jul 2;220(3):432-441. doi: 10.1093/infdis/jiz127. Erratum in: J Infect Dis. 2020 Jan 14;221(3):493.

39.

Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential: A Modeling Study.

Dugdale CM, Ciaranello AL, Bekker LG, Stern ME, Myer L, Wood R, Sax PE, Abrams EJ, Freedberg KA, Walensky RP.

Ann Intern Med. 2019 May 7;170(9):614-625. doi: 10.7326/M18-3358. Epub 2019 Apr 2.

40.

Design of an Implant for Long-Acting HIV Pre-Exposure Prophylaxis: Input from South African Health Care Providers.

Krogstad EA, Montgomery ET, Atujuna M, Minnis AM, O'Rourke S, Ahmed K, Bekker LG, van der Straten A.

AIDS Patient Care STDS. 2019 Apr;33(4):157-166. doi: 10.1089/apc.2018.0177.

PMID:
30932697
41.

Targeting and vaccine durability are key for population-level impact and cost-effectiveness of a pox-protein HIV vaccine regimen in South Africa.

Selinger C, Bershteyn A, Dimitrov DT, Adamson BJS, Revill P, Hallett TB, Phillips AN, Bekker LG, Rees H, Gray G.

Vaccine. 2019 Apr 10;37(16):2258-2267. doi: 10.1016/j.vaccine.2019.02.073. Epub 2019 Mar 16.

42.

The Invisible Product: Preferences for Sustained-Release, Long-Acting Pre-exposure Prophylaxis to HIV Among South African Youth.

Montgomery ET, Atujuna M, Krogstad E, Hartmann M, Ndwayana S, OʼRourke S, Bekker LG, van der Straten A, Minnis AM.

J Acquir Immune Defic Syndr. 2019 Apr 15;80(5):542-550. doi: 10.1097/QAI.0000000000001960.

PMID:
30865050
43.

PrEP as a Lifestyle and Investment for Adolescent Girls and Young Women in Sub-Saharan Africa.

Haberer JE, Mugo N, Baeten JM, Pyra M, Bukusi E, Bekker LG.

J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219831011. doi: 10.1177/2325958219831011.

44.

Organisational best practices towards gender equality in science and medicine.

Coe IR, Wiley R, Bekker LG.

Lancet. 2019 Feb 9;393(10171):587-593. doi: 10.1016/S0140-6736(18)33188-X. Review.

PMID:
30739694
45.

HIV prevalence and determinants of loss-to-follow-up in adolescents and young adults with tuberculosis in Cape Town.

Mulongeni P, Hermans S, Caldwell J, Bekker LG, Wood R, Kaplan R.

PLoS One. 2019 Feb 5;14(2):e0210937. doi: 10.1371/journal.pone.0210937. eCollection 2019.

46.

Global PrEP roll-out: recommendations for programmatic success.

Rivet Amico K, Bekker LG.

Lancet HIV. 2019 Feb;6(2):e137-e140. doi: 10.1016/S2352-3018(19)30002-5. Epub 2019 Jan 16.

PMID:
30660592
47.

Factors affecting linkage to HIV care and ART initiation following referral for ART by a mobile health clinic in South Africa: evidence from a multimethod study.

Maughan-Brown B, Harrison A, Galárraga O, Kuo C, Smith P, Bekker LG, Lurie MN.

J Behav Med. 2019 Oct;42(5):883-897. doi: 10.1007/s10865-018-0005-x. Epub 2019 Jan 11.

48.

A review of the atomoRapid HIV self-testing device: an acceptable and easy alternative to facilitate HIV testing.

Smith P, Clayton J, Pike C, Bekker LG.

Expert Rev Mol Diagn. 2019 Jan;19(1):9-14. doi: 10.1080/14737159.2019.1561286. Epub 2019 Jan 10.

PMID:
30570364
49.

Sexual reproductive healthcare utilisation and HIV testing in an integrated adolescent youth centre clinic in Cape Town, South Africa.

Mendelsohn AS, Gill K, Marcus R, Robbertze D, van de Venter C, Mendel E, Mzukwa L, Bekker LG.

South Afr J HIV Med. 2018 Nov 26;19(1):826. doi: 10.4102/sajhivmed.v19i1.826. eCollection 2018.

50.

Field responsive mechanical metamaterials.

Jackson JA, Messner MC, Dudukovic NA, Smith WL, Bekker L, Moran B, Golobic AM, Pascall AJ, Duoss EB, Loh KJ, Spadaccini CM.

Sci Adv. 2018 Dec 7;4(12):eaau6419. doi: 10.1126/sciadv.aau6419. eCollection 2018 Dec.

Supplemental Content

Loading ...
Support Center